Skip to main content
Top
Published in: Inflammation 5/2015

01-10-2015

miR-146a-5p Antagonized AGEs- and P.g-LPS-Induced ABCA1 and ABCG1 Dysregulation in Macrophages via IRAK-1 Downregulation

Authors: Xia Li, Zheng Ji, Si Li, Ya-Nan Sun, Jia Liu, Ying Liu, Wei Tian, Yun-Tao Zhou, Xiao-Ming Shang

Published in: Inflammation | Issue 5/2015

Login to get access

Abstract

The miR-146-mediated IL-1 receptor-associated kinase 1 (IRAK-1) feedback circuit has been shown to inhibit inflammatory response in macrophages against lipopolysaccharide (LPS). The aim of this study is to compare the antagonized effects of miR-146a-5p on Porphyromonas gingivalis (P.g) lipolysaccharide (LPS)- and advanced glycation end products (AGEs)-triggered ABCA1 and ABCG1 dysregulation and explore the underlying mechanism. THP-1-derived macrophages transfected with miRNA mimics or not were treated with P.g LPS or AGE-BSA, respectively. The mechanism of endotoxin tolerance was mimicked. miR-146a-5p levels and protein levels of IRAK-1, LXRα/β, ABCA1, and ABCG1 were detected by stem–loop reverse transcription followed by TaqMan PCR analysis and Western blotting. Our results showed that miR-146a-5p levels were significantly increased in macrophages after 24 h of stimulation with high dose of P.g LPS or AGE-BSA. Macrophages transfected with miR-146a-5p mimics attenuated the dysregulation of ABCA1/G1 induced by P.g LPS and AGEs through IRAK-1 downregulation. In low-dose LPS-tolerized cells, elevated miR-146a-5p antagonized the increase of ABCA1, ABCG1, and IRAK-1. However, low-dose AGE-BSA did not increase miR-146a-5p levels. In conclusion, the model of endotoxin tolerance is suitable for the antagonistic effects on the dysregulation of ABCA1/G1 induced by high dose of P.g LPS. Conversely, low-dose AGEs did not induce the model of P.g LPS-mediated tolerance.
Literature
1.
go back to reference Bolego, C., A. Cignarella, B. Staels, and G. Chinetti-Gbaguidi. 2013. Macrophage function and polarization in cardiovascular disease: a role of estrogen signaling? Arteriosclerosis, Thrombosis, and Vascular Biology 33: 1127–1134.CrossRefPubMed Bolego, C., A. Cignarella, B. Staels, and G. Chinetti-Gbaguidi. 2013. Macrophage function and polarization in cardiovascular disease: a role of estrogen signaling? Arteriosclerosis, Thrombosis, and Vascular Biology 33: 1127–1134.CrossRefPubMed
2.
4.
go back to reference Kzhyshkowska, J., C. Neyen, and S. Gordon. 2012. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 217: 492–502.CrossRefPubMed Kzhyshkowska, J., C. Neyen, and S. Gordon. 2012. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 217: 492–502.CrossRefPubMed
5.
go back to reference Lundberg, A.M., and G.K. Hansson. 2010. Innate immune signals in atherosclerosis. Clinical Immunology 134: 5–24.CrossRefPubMed Lundberg, A.M., and G.K. Hansson. 2010. Innate immune signals in atherosclerosis. Clinical Immunology 134: 5–24.CrossRefPubMed
6.
go back to reference Goldin, A., J.A. Beckman, A.M. Schmidt, and M.A. Creager. 2006. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114: 597–605.CrossRefPubMed Goldin, A., J.A. Beckman, A.M. Schmidt, and M.A. Creager. 2006. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114: 597–605.CrossRefPubMed
7.
go back to reference Liu, H.Q., X.Y. Zhang, K. Edfeldt, M.O. Nijhuis, H. Idborg, M. Bäck, J. Roy, U. Hedin, P.-J. Jakobsson, J.D. Laman, D.P. de Kleijn, G. Pasterkamp, G.K. Hansson, and Z.Q. Yan. 2013. NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 33: 2193–2201.CrossRefPubMed Liu, H.Q., X.Y. Zhang, K. Edfeldt, M.O. Nijhuis, H. Idborg, M. Bäck, J. Roy, U. Hedin, P.-J. Jakobsson, J.D. Laman, D.P. de Kleijn, G. Pasterkamp, G.K. Hansson, and Z.Q. Yan. 2013. NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 33: 2193–2201.CrossRefPubMed
8.
go back to reference Cao, F., A. Castrillo, P. Tontonoz, F. Re, and G.I. Byrne. 2007. Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by toll-like receptor 2. Infection and Immunity 75: 753–759.PubMedCentralCrossRefPubMed Cao, F., A. Castrillo, P. Tontonoz, F. Re, and G.I. Byrne. 2007. Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by toll-like receptor 2. Infection and Immunity 75: 753–759.PubMedCentralCrossRefPubMed
9.
go back to reference Zheng, F., S. Xing, Z. Gong, W. Mu, and Q. Xing. 2014. Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice. Mediators of Inflammation 2014: 8. Zheng, F., S. Xing, Z. Gong, W. Mu, and Q. Xing. 2014. Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice. Mediators of Inflammation 2014: 8.
10.
go back to reference Fedele, S., W. Sabbah, N. Donos, S. Porter, and F. D’Aiuto. 2011. Common oral mucosal diseases, systemic inflammation, and cardiovascular diseases in a large cross-sectional US survey. American Heart Journal 161: 344–350.CrossRefPubMed Fedele, S., W. Sabbah, N. Donos, S. Porter, and F. D’Aiuto. 2011. Common oral mucosal diseases, systemic inflammation, and cardiovascular diseases in a large cross-sectional US survey. American Heart Journal 161: 344–350.CrossRefPubMed
11.
go back to reference Southerland, J.H., K. Moss, G.W. Taylor, J.D. Beck, J. Pankow, P.R. Gangula, and S. Offenbacher. 2012. Periodontitis and diabetes associations with measures of atherosclerosis and CHD. Atherosclerosis 222: 196–201.CrossRefPubMed Southerland, J.H., K. Moss, G.W. Taylor, J.D. Beck, J. Pankow, P.R. Gangula, and S. Offenbacher. 2012. Periodontitis and diabetes associations with measures of atherosclerosis and CHD. Atherosclerosis 222: 196–201.CrossRefPubMed
12.
go back to reference Buhlin, K., P. Mäntylä, S. Paju, J.S. Peltola, M.S. Nieminen, J. Sinisalo, and P.J. Pussinen. 2011. Periodontitis is associated with angiographically verified coronary artery disease. Journal of Clinical Periodontology 38: 1007–1014.CrossRefPubMed Buhlin, K., P. Mäntylä, S. Paju, J.S. Peltola, M.S. Nieminen, J. Sinisalo, and P.J. Pussinen. 2011. Periodontitis is associated with angiographically verified coronary artery disease. Journal of Clinical Periodontology 38: 1007–1014.CrossRefPubMed
13.
go back to reference Zhang, D., L. Chen, S. Li, G. Zhiyuan, and J. Yan. 2008. Lipopolysaccharide (LPS) of porphyromonas gingivalis induces IL-1β, TNF-α and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immunity 14: 99–107.CrossRef Zhang, D., L. Chen, S. Li, G. Zhiyuan, and J. Yan. 2008. Lipopolysaccharide (LPS) of porphyromonas gingivalis induces IL-1β, TNF-α and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immunity 14: 99–107.CrossRef
14.
go back to reference Liu, J., S. Zhao, J. Tang, Z. Li, T. Zhong, Y. Liu, D. Chen, M. Zhao, Y. Li, X. Gong, P. Deng, J.H. Wang, and Y. Jiang. 2009. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-κB. FEBS Journal 276: 4598–4606.CrossRefPubMed Liu, J., S. Zhao, J. Tang, Z. Li, T. Zhong, Y. Liu, D. Chen, M. Zhao, Y. Li, X. Gong, P. Deng, J.H. Wang, and Y. Jiang. 2009. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-κB. FEBS Journal 276: 4598–4606.CrossRefPubMed
15.
go back to reference Isoda, K., E.J. Folco, K. Shimizu, and P. Libby. 2007. AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL. Atherosclerosis 192: 298–304.CrossRefPubMed Isoda, K., E.J. Folco, K. Shimizu, and P. Libby. 2007. AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL. Atherosclerosis 192: 298–304.CrossRefPubMed
16.
go back to reference Passarelli, M., C. Tang, T.O. McDonald, K.D. O’Brien, R.G. Gerrity, J.W. Heinecke, and J.F. Oram. 2005. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 54: 2198–2205.CrossRefPubMed Passarelli, M., C. Tang, T.O. McDonald, K.D. O’Brien, R.G. Gerrity, J.W. Heinecke, and J.F. Oram. 2005. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 54: 2198–2205.CrossRefPubMed
17.
go back to reference Veloso, C.A., J.S. Fernandes, C.M. Volpe, F.S. Fagundes-Netto, J.S. Reis, M.M. Chaves, and J.A. Nogueira-Machado. 2011. TLR4 and RAGE: similar routes leading to inflammation in type 2 diabetic patients. Diabetes & Metabolism 336–342. Veloso, C.A., J.S. Fernandes, C.M. Volpe, F.S. Fagundes-Netto, J.S. Reis, M.M. Chaves, and J.A. Nogueira-Machado. 2011. TLR4 and RAGE: similar routes leading to inflammation in type 2 diabetic patients. Diabetes & Metabolism 336–342.
18.
go back to reference Lin, L. 2006. RAGE on the Toll Road? Cell Molecular Immunology 3: 351–358. Lin, L. 2006. RAGE on the Toll Road? Cell Molecular Immunology 3: 351–358.
19.
go back to reference Ibrahim, Z.A., C.L. Armour, S. Phipps, and M.B. Sukkar. 2013. RAGE and TLRs: relatives, friends or neighbours? Molecular Immunology 56: 739–744.CrossRefPubMed Ibrahim, Z.A., C.L. Armour, S. Phipps, and M.B. Sukkar. 2013. RAGE and TLRs: relatives, friends or neighbours? Molecular Immunology 56: 739–744.CrossRefPubMed
20.
go back to reference Monaco, C., and E. Paleolog. 2004. Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 61: 671–682. Monaco, C., and E. Paleolog. 2004. Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 61: 671–682.
21.
go back to reference Lu, Z., X. Zhang, Y. Li, J. Jin, and Y. Huang. 2013. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. Journal of Endocrinology 216: 61–71.CrossRefPubMed Lu, Z., X. Zhang, Y. Li, J. Jin, and Y. Huang. 2013. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. Journal of Endocrinology 216: 61–71.CrossRefPubMed
22.
go back to reference Boldin, M.P., K.D. Taganov, D.S. Rao, L. Yang, J.L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, and J. Xu. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. The Journal of Experimental Medicine 208: 1189–1201.PubMedCentralCrossRefPubMed Boldin, M.P., K.D. Taganov, D.S. Rao, L. Yang, J.L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, and J. Xu. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. The Journal of Experimental Medicine 208: 1189–1201.PubMedCentralCrossRefPubMed
23.
go back to reference Villarreal, A., R.X. Aviles Reyes, M.F. Angelo, A.G. Reines, and A.J. Ramos. 2011. S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling. Journal of Neurochemistry 117: 321–332.CrossRefPubMed Villarreal, A., R.X. Aviles Reyes, M.F. Angelo, A.G. Reines, and A.J. Ramos. 2011. S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling. Journal of Neurochemistry 117: 321–332.CrossRefPubMed
24.
go back to reference Daigneault, M., J.A. Preston, H.M. Marriott, M.K.B. Whyte, and D.H. Dockrell. 2010. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5: e8668.PubMedCentralCrossRefPubMed Daigneault, M., J.A. Preston, H.M. Marriott, M.K.B. Whyte, and D.H. Dockrell. 2010. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5: e8668.PubMedCentralCrossRefPubMed
25.
go back to reference Nahid, M.A., K.M. Pauley, M. Satoh, and E.K.L. Chan. 2009. miR-146a is critical for endotoxin-induced tolerance. Journal of Biological Chemistry 284: 34590.PubMedCentralCrossRefPubMed Nahid, M.A., K.M. Pauley, M. Satoh, and E.K.L. Chan. 2009. miR-146a is critical for endotoxin-induced tolerance. Journal of Biological Chemistry 284: 34590.PubMedCentralCrossRefPubMed
26.
go back to reference Taganov, K.D., M.P. Boldin, K.J. Chang, and D. Baltimore. 2006. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences 103: 12481–12486.CrossRef Taganov, K.D., M.P. Boldin, K.J. Chang, and D. Baltimore. 2006. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences 103: 12481–12486.CrossRef
27.
go back to reference Park, D.W., H.K. Lee, J.H. Lyu, H. Chin, S.W. Kang, Y.J. Kim, Y.S. Bae, and S.H. Baek. 2013. TLR2 stimulates ABCA1 expression via PKC-η and PLD2 pathway. Biochemical and Biophysical Research Communications 430: 933–937.CrossRefPubMed Park, D.W., H.K. Lee, J.H. Lyu, H. Chin, S.W. Kang, Y.J. Kim, Y.S. Bae, and S.H. Baek. 2013. TLR2 stimulates ABCA1 expression via PKC-η and PLD2 pathway. Biochemical and Biophysical Research Communications 430: 933–937.CrossRefPubMed
28.
go back to reference Oerlemans, M.I.F.J., A. Mosterd, M.S. Dekker, E.A. de Vrey, A. van Mil, G. Pasterkamp, P.A. Doevendans, A.W. Hoes, and J.P.G. Sluijter. 2012. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Molecular Medicine 4: 1176–1185.PubMedCentralCrossRefPubMed Oerlemans, M.I.F.J., A. Mosterd, M.S. Dekker, E.A. de Vrey, A. van Mil, G. Pasterkamp, P.A. Doevendans, A.W. Hoes, and J.P.G. Sluijter. 2012. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Molecular Medicine 4: 1176–1185.PubMedCentralCrossRefPubMed
29.
go back to reference Guo, M., X. Mao, Q. Ji, M. Lang, S. Li, Y. Peng, W. Zhou, B. Xiong, and Q. Zeng. 2010. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunology and Cell Biology 88: 555–564.CrossRefPubMed Guo, M., X. Mao, Q. Ji, M. Lang, S. Li, Y. Peng, W. Zhou, B. Xiong, and Q. Zeng. 2010. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunology and Cell Biology 88: 555–564.CrossRefPubMed
30.
go back to reference Nicole, R., and M. Silvia. 2011. MiR-146a in immunity and disease. Molecular Biology International 2011: 437301. Nicole, R., and M. Silvia. 2011. MiR-146a in immunity and disease. Molecular Biology International 2011: 437301.
31.
go back to reference Bhaumik, D., G. Scott, S. Schokrpur, C. Patil, A. Orjalo, F. Rodier, G. Lithgow, and J. Campisi. 2009. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) 1: 402–411. Bhaumik, D., G. Scott, S. Schokrpur, C. Patil, A. Orjalo, F. Rodier, G. Lithgow, and J. Campisi. 2009. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) 1: 402–411.
32.
go back to reference Meisgen, F., N.X. Landen, A. Wang, B. Rethi, C. Bouez, M. Zuccolo, A. Gueniche, M. Stahle, E. Sonkoly, L. Breton, and A. Pivarcsi. 2014. MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. Journal of Investigative Dermatology 134: 1931–1940.CrossRefPubMed Meisgen, F., N.X. Landen, A. Wang, B. Rethi, C. Bouez, M. Zuccolo, A. Gueniche, M. Stahle, E. Sonkoly, L. Breton, and A. Pivarcsi. 2014. MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. Journal of Investigative Dermatology 134: 1931–1940.CrossRefPubMed
33.
go back to reference Saba, R., S. Gushue, R.L.C.H. Huzarewich, K. Manguiat, S. Medina, C. Robertson, and S.A. Booth. 2012. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS ONE 7: e30832.PubMedCentralCrossRefPubMed Saba, R., S. Gushue, R.L.C.H. Huzarewich, K. Manguiat, S. Medina, C. Robertson, and S.A. Booth. 2012. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS ONE 7: e30832.PubMedCentralCrossRefPubMed
34.
go back to reference Conze, D.B., C.-J. Wu, J.A. Thomas, A. Landstrom, and J.D. Ashwell. 2008. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Molecular and Cellular Biology 28: 3538–3547.PubMedCentralCrossRefPubMed Conze, D.B., C.-J. Wu, J.A. Thomas, A. Landstrom, and J.D. Ashwell. 2008. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Molecular and Cellular Biology 28: 3538–3547.PubMedCentralCrossRefPubMed
35.
go back to reference Deng, C., C. Radu, A. Diab, M.F. Tsen, R. Hussain, J.S. Cowdery, M.K. Racke, and J.A. Thomas. 2003. IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity. The Journal of Immunology 170: 2833–2842.CrossRefPubMed Deng, C., C. Radu, A. Diab, M.F. Tsen, R. Hussain, J.S. Cowdery, M.K. Racke, and J.A. Thomas. 2003. IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity. The Journal of Immunology 170: 2833–2842.CrossRefPubMed
36.
go back to reference Lakoski, S.G., L. Li, C.D. Langefeld, Y. Liu, T.D. Howard, K.B. Brosnihan, J. Xu, D.W. Bowden, and D.M. Herrington. 2007. The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study. Experimental and Molecular Pathology 82: 280–283.PubMedCentralCrossRefPubMed Lakoski, S.G., L. Li, C.D. Langefeld, Y. Liu, T.D. Howard, K.B. Brosnihan, J. Xu, D.W. Bowden, and D.M. Herrington. 2007. The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study. Experimental and Molecular Pathology 82: 280–283.PubMedCentralCrossRefPubMed
37.
go back to reference Maitra, U., J.S. Parks, and L. Li. 2009. An innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor α and NFATc2. Molecular and Cellular Biology 29: 5989–5997.PubMedCentralCrossRefPubMed Maitra, U., J.S. Parks, and L. Li. 2009. An innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor α and NFATc2. Molecular and Cellular Biology 29: 5989–5997.PubMedCentralCrossRefPubMed
38.
go back to reference Zhu, P., M. Ren, C. Yang, Y.-X. Hu, J.-M. Ran, and L. Yan. 2012. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Experimental Dermatology 21: 123–129.CrossRefPubMed Zhu, P., M. Ren, C. Yang, Y.-X. Hu, J.-M. Ran, and L. Yan. 2012. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Experimental Dermatology 21: 123–129.CrossRefPubMed
39.
go back to reference Liu, Y., C. Liang, X. Liu, B. Liao, X. Pan, Y. Ren, M. Fan, M. Li, Z. He, J. Wu, and Z. Wu. 2010. AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-κB pathways. Atherosclerosis 208: 34–42.CrossRefPubMed Liu, Y., C. Liang, X. Liu, B. Liao, X. Pan, Y. Ren, M. Fan, M. Li, Z. He, J. Wu, and Z. Wu. 2010. AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-κB pathways. Atherosclerosis 208: 34–42.CrossRefPubMed
40.
go back to reference Ramasamy, R., S.F. Yan, and A.M. Schmidt. 2009. RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts. Journal of Leukocyte Biology 86: 505–512.CrossRefPubMed Ramasamy, R., S.F. Yan, and A.M. Schmidt. 2009. RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts. Journal of Leukocyte Biology 86: 505–512.CrossRefPubMed
41.
go back to reference Ishibashi, Y., T. Matsui, M. Takeuchi, and S. Yamagishi. 2011. Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1. Hormone and Metabolic Research 43: 619–624.CrossRefPubMed Ishibashi, Y., T. Matsui, M. Takeuchi, and S. Yamagishi. 2011. Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1. Hormone and Metabolic Research 43: 619–624.CrossRefPubMed
Metadata
Title
miR-146a-5p Antagonized AGEs- and P.g-LPS-Induced ABCA1 and ABCG1 Dysregulation in Macrophages via IRAK-1 Downregulation
Authors
Xia Li
Zheng Ji
Si Li
Ya-Nan Sun
Jia Liu
Ying Liu
Wei Tian
Yun-Tao Zhou
Xiao-Ming Shang
Publication date
01-10-2015
Publisher
Springer US
Published in
Inflammation / Issue 5/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-015-0153-x

Other articles of this Issue 5/2015

Inflammation 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.